RxAmnion
Thomas Burks is a seasoned professional in the biologics and pharmaceutical industries, currently serving as the Director of Patient Care at RxWound since May 2025, where responsibilities include promoting FDA-compliant regenerative biologic products. Previously, Thomas worked as an Analyst V at Zoetis, focusing on HPLC testing and data management. Experience as a QC Associate III at AGC Biologics involved analytical protein chemistry testing in a GMP environment, while earlier roles at KBI Biopharma and BioPlx Microbiomics highlighted expertise in method development and environmental engineering. Academic qualifications include a Master of Science in Chemical Biology from Friedrich Schiller University Jena and a Bachelor of Science in Chemistry from Technische Universität Berlin.
This person is not in any teams
This person is not in any offices
RxAmnion
At RxAmnion, we provide Amniotic Membrane Allografts to treat chronic wound and ocular conditions. Our grafts are safe, FDA registered, tested for communicable disease, and chorion free. We provide you with an ethically procured product and back office support staff that will ensure consistent reimbursement.
Employees
51-200